APA (7th ed.) Citation

Nakamura, N., Honzawa, Y., Ito, Y., Sano, Y., Yagi, N., Kobayashi, S., . . . Naganuma, M. (2025). Leucine-rich alpha-2 glycoprotein is useful in predicting clinical relapse in patients with Crohn's disease during biological remission. Intestinal Research, 23(2), 170. https://doi.org/10.5217/ir.2024.00042

Chicago Style (17th ed.) Citation

Nakamura, Naohiro, et al. "Leucine-rich Alpha-2 Glycoprotein Is Useful in Predicting Clinical Relapse in Patients with Crohn's Disease During Biological Remission." Intestinal Research 23, no. 2 (2025): 170. https://doi.org/10.5217/ir.2024.00042.

MLA (9th ed.) Citation

Nakamura, Naohiro, et al. "Leucine-rich Alpha-2 Glycoprotein Is Useful in Predicting Clinical Relapse in Patients with Crohn's Disease During Biological Remission." Intestinal Research, vol. 23, no. 2, 2025, p. 170, https://doi.org/10.5217/ir.2024.00042.